A five-year, $3.9 million grant from the National Institutes of Health will help establish a joint Baylor College of Medicine/Rice University center to support the development and testing of new genome editing technologies.
The Advanced Research Projects Agency for Health has awarded a Rice-led team $45 million to rapidly develop an implant with sense-and-respond technology that could slash U.S. cancer-related deaths by more than 50%.
Rice University today introduced the Rice Biotech Launch Pad, a Houston-based accelerator focused on expediting the translation of the university’s health and medical technology discoveries into cures.
Rice U. engineers developed a lightweight, wearable textile-based device that can deliver complex haptic cues, enabling a user to perform open-world navigation tasks. The device is resilient to regular daily use, withstanding multiple cycles of washing and other damage and repair without loss of function.
Two leading experts in the biomedical engineering field, Michael King and Cynthia Reinhart-King, whose research programs have advanced the understanding and treatment of cancer and other diseases, will join the Rice University faculty next year.
In order to deepen and broaden the partnership between Rice University and the Indian Institute of Technology Kanpur (IITK), Rice Global recently welcomed a delegation from the institute to the university for a day-long meeting.
Rice U. bioengineers developed a platform that enhances survival and function of probiotics engineered to diagnose inflammatory bowel disease in animals. The technology holds promise for minimally invasive disease monitoring and advanced smart therapeutics.
Rice University and the Indian Institute of Technology Kanpur have taken an important next step in their strategic research and education partnership with the announcement of the first recipients of the Rice-IITK Strategic Collaboration Award program.
Rice bioengineer Caleb Bashor and colleagues have developed a generalizable method to address “off-target” gene activation, a significant problem in the field of synthetic biology. Taking a cue from nature, the researchers showed they could all but eliminate the activation of off-target genes by designing weak transcription factors that cooperatively assemble.
The Rice360 Institute for Global Health Technologies has validated the accuracy of its latest testing technology for newborn jaundice. BiliDx addresses a critical gap in the availability of accurate, affordable, point-of-care jaundice testing in low-resource hospitals.
Rice University’s Global Medical Innovation program combines engineering, business and clinical training to help students solve real-world medical needs.
A team of Rice University engineers has launched open-source software that constructs and uses personalized computer models of how individual patients move to optimize treatments for neurologic and orthopedic mobility impairments.
Rising Rice seniors Maria Hancu, Alex Lin, Ryan Wang and Ruofeng “Charlie” Liu are the latest Owls to win the coveted Goldwater Scholarship, one of the most prestigious honors bestowed each year upon pioneering STEM undergraduates across the country planning to pursue doctoral degrees.